US Patent 7695716 Methods of treating neoplastic, autoimmune and inflammatory diseases

Patent 7695716 was granted and assigned to Seagen on April, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Seagen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7695716

Date of Patent

April 13, 2010

Patent Application Number

12101785

Date Filed

April 11, 2008

Patent Citations Received

‌

US Patent 12005081 Chimeric receptors and methods of use thereof

‌

US Patent 11912784 Methods of treating an eye disorder

Patent Primary Examiner

‌

Karen A. Canella

Patent abstract

Methods of treating cancer and autoimmune and inflammatory diseases are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7695716 Methods of treating neoplastic, autoimmune and inflammatory diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API